Cargando…

A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK

BACKGROUND: Cannabidiol (CBD)-containing products are sold widely in consumer stores, but concerns have been raised regarding their quality, with notable discrepancies between advertised and actual CBD content. Information is limited regarding how different types of CBD products may differ in their...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Drusus A., Hogan, Megan, Marriot, Ray, Heaney, Liam M., Bailey, Stephen J., Clifford, Tom, James, Lewis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339496/
https://www.ncbi.nlm.nih.gov/pubmed/37438849
http://dx.doi.org/10.1186/s42238-023-00183-y
_version_ 1785071856780312576
author Johnson, Drusus A.
Hogan, Megan
Marriot, Ray
Heaney, Liam M.
Bailey, Stephen J.
Clifford, Tom
James, Lewis J.
author_facet Johnson, Drusus A.
Hogan, Megan
Marriot, Ray
Heaney, Liam M.
Bailey, Stephen J.
Clifford, Tom
James, Lewis J.
author_sort Johnson, Drusus A.
collection PubMed
description BACKGROUND: Cannabidiol (CBD)-containing products are sold widely in consumer stores, but concerns have been raised regarding their quality, with notable discrepancies between advertised and actual CBD content. Information is limited regarding how different types of CBD products may differ in their deviation from advertised CBD concentrations. Therefore, CBD concentrations were quantified and compared in aqueous tinctures, oils, e-liquids and drinks. METHODS: Products (13 aqueous tinctures, 29 oils, 10 e-liquids and 11 drinks) were purchased online in the UK. CBD concentrations were quantified in aqueous tinctures, oils and e-liquids via high performance liquid chromatography (HPLC), and in drinks via gas chromatograhy-mass spectrometry (GC-MS). RESULTS: Measured concentrations fell −25.7 ± 17.3, −6.1 ± 7.8, −6.9 ± 4.6 and − 0.03 ± 0.06 mg/mL below advertised concentrations for aqueous tinctures, oils, e-liquids and drinks, respectively (medians ± interquartile ranges; p < .05). Oils deviated relatively less (−19.0 ± 14.5%) from advertised concentrations than e-liquids (−29.2 ± 10.2%), aqueous tinctures (−51.4 ± 41.4%) and drinks (−65.6 ± 36.5%; p < .01), whilst e-liquids deviated less than aqueous tinctures and drinks (p < .05), and deviation was not different between aqueous tinctures and drinks (p = .19). Only 5/63 (8%) products had measured concentrations within 10% of advertised concentrations. DISCUSSION: Similarly to previous studies, few products had measured CBD concentrations within 10% of advertised concentrations, with most falling below advertised concentrations. All individual product types deviated from advertised concentrations, with oils deviating least. These findings may be indicative of poor manufacturing standards, or that CBD undergoes degradation in consumer products. This reinforces concerns over quality of CBD-containing consumer products and may highlight the need for improved regulation of such products.
format Online
Article
Text
id pubmed-10339496
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103394962023-07-14 A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK Johnson, Drusus A. Hogan, Megan Marriot, Ray Heaney, Liam M. Bailey, Stephen J. Clifford, Tom James, Lewis J. J Cannabis Res Brief Research Report BACKGROUND: Cannabidiol (CBD)-containing products are sold widely in consumer stores, but concerns have been raised regarding their quality, with notable discrepancies between advertised and actual CBD content. Information is limited regarding how different types of CBD products may differ in their deviation from advertised CBD concentrations. Therefore, CBD concentrations were quantified and compared in aqueous tinctures, oils, e-liquids and drinks. METHODS: Products (13 aqueous tinctures, 29 oils, 10 e-liquids and 11 drinks) were purchased online in the UK. CBD concentrations were quantified in aqueous tinctures, oils and e-liquids via high performance liquid chromatography (HPLC), and in drinks via gas chromatograhy-mass spectrometry (GC-MS). RESULTS: Measured concentrations fell −25.7 ± 17.3, −6.1 ± 7.8, −6.9 ± 4.6 and − 0.03 ± 0.06 mg/mL below advertised concentrations for aqueous tinctures, oils, e-liquids and drinks, respectively (medians ± interquartile ranges; p < .05). Oils deviated relatively less (−19.0 ± 14.5%) from advertised concentrations than e-liquids (−29.2 ± 10.2%), aqueous tinctures (−51.4 ± 41.4%) and drinks (−65.6 ± 36.5%; p < .01), whilst e-liquids deviated less than aqueous tinctures and drinks (p < .05), and deviation was not different between aqueous tinctures and drinks (p = .19). Only 5/63 (8%) products had measured concentrations within 10% of advertised concentrations. DISCUSSION: Similarly to previous studies, few products had measured CBD concentrations within 10% of advertised concentrations, with most falling below advertised concentrations. All individual product types deviated from advertised concentrations, with oils deviating least. These findings may be indicative of poor manufacturing standards, or that CBD undergoes degradation in consumer products. This reinforces concerns over quality of CBD-containing consumer products and may highlight the need for improved regulation of such products. BioMed Central 2023-07-13 /pmc/articles/PMC10339496/ /pubmed/37438849 http://dx.doi.org/10.1186/s42238-023-00183-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Brief Research Report
Johnson, Drusus A.
Hogan, Megan
Marriot, Ray
Heaney, Liam M.
Bailey, Stephen J.
Clifford, Tom
James, Lewis J.
A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title_full A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title_fullStr A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title_full_unstemmed A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title_short A comparison of advertised versus actual cannabidiol (CBD) content of oils, aqueous tinctures, e-liquids and drinks purchased in the UK
title_sort comparison of advertised versus actual cannabidiol (cbd) content of oils, aqueous tinctures, e-liquids and drinks purchased in the uk
topic Brief Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339496/
https://www.ncbi.nlm.nih.gov/pubmed/37438849
http://dx.doi.org/10.1186/s42238-023-00183-y
work_keys_str_mv AT johnsondrususa acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT hoganmegan acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT marriotray acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT heaneyliamm acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT baileystephenj acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT cliffordtom acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT jameslewisj acomparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT johnsondrususa comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT hoganmegan comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT marriotray comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT heaneyliamm comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT baileystephenj comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT cliffordtom comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk
AT jameslewisj comparisonofadvertisedversusactualcannabidiolcbdcontentofoilsaqueoustinctureseliquidsanddrinkspurchasedintheuk